Charles Schwab
HOOK

Charles Schwab’s HOOKIPA Pharma HOOK Stock Holding History

Charles Schwab’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,641
Closed -$21.5K – 3535
2024
Q2 		$21.5K Buy
3,641
+12
+0.3% +$95 ﹤0.01% 3582
2024
Q1 		$25.8K Hold
3,629
– – ﹤0.01% 3423
2023
Q4 		$29.4K Hold
3,629
– – ﹤0.01% 3450
2023
Q3 		$22.4K Hold
3,629
– – ﹤0.01% 3505
2023
Q2 		$31.9K Hold
3,629
– – ﹤0.01% 3494
2023
Q1 		$26.7K Hold
3,629
– – ﹤0.01% 3469
2022
Q4 		$29.4K Hold
3,629
– – ﹤0.01% 3459
2022
Q3 		$49K Buy
+3,629
New +$55.7K ﹤0.01% 3332
2022
Q2 		– Sell
-4,069
Closed -$93K – 3586
2022
Q1 		$93K Sell
4,069
-700
-15% -$12.5K ﹤0.01% 3427
2021
Q4 		$112K Hold
4,769
– – ﹤0.01% 3424
2021
Q3 		$281K Hold
4,769
– – ﹤0.01% 3280
2021
Q2 		$437K Buy
4,769
+995
+26% +$133K ﹤0.01% 3196
2021
Q1 		$508K Buy
3,774
+515
+16% +$62.1K ﹤0.01% 3072
2020
Q4 		$362K Hold
3,259
– – ﹤0.01% 3096
2020
Q3 		$309K Buy
3,259
+580
+22% +$59.1K ﹤0.01% 3019
2020
Q2 		$312K Buy
2,679
+547
+26% +$53.3K ﹤0.01% 3027
2020
Q1 		$176K Hold
2,132
– – ﹤0.01% 3032
2019
Q4 		$261K Buy
+2,132
New +$181K ﹤0.01% 3004

Other funds holding HOOK

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Charles Schwab's HOOK Position: Q3 2024 in Review

Charles Schwab sold out of HOOKIPA Pharma (HOOK) in Q3 2024, closing a stake of 3,641 shares — an estimated $21.5K sold.

Charles Schwab first reported a position in HOOK in Q4 2019 and held it in 18 quarters. The position peaked at $508K in Q1 2021. 35 funds tracked by Wall St. Rank hold HOOK as of Q3 2024.

  • Charles Schwab reported no remaining HOOKIPA Pharma position as of Q3 2024 after selling out during the quarter.
  • Charles Schwab sold 3,641 HOOKIPA Pharma shares in Q3 2024, an estimated $21.5K.
  • Charles Schwab first reported a position in HOOKIPA Pharma in Q4 2019 and held it in 18 quarters.
  • Charles Schwab's HOOKIPA Pharma position peaked at $508K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.